MEGAN KARLEEN: Open Payments
NPI 1306174024 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 84 payments from 15 companies in 2025. Trend: 2023 $535 · 2024 $1,189 · 2025 $1,519
Food & beverage: $1,453Education: $66
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $434 |
| Lilly USA, LLC | 15 | $269 |
| Janssen Biotech, Inc. | 16 | $248 |
| UCB, Inc. | 14 | $203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Biofrontera Inc. | 1 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Amgen Inc. | 2 | $31 |
| GENZYME CORPORATION | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: TREMFYA, Bimzelx, SKYRIZI, BOTOX, TALTZ, EBGLYSS, DUPIXENT, RINVOQ.
Industry payments across NV — which companies pay providers there.
